Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
- 19 January 2008
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 20 (8) , 1409-1414
- https://doi.org/10.1016/j.cellsig.2008.01.006
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- FAK Is Required for TGFβ-induced JNK Phosphorylation in Fibroblasts: Implications for Acquisition of a Matrix-remodeling PhenotypeMolecular Biology of the Cell, 2007
- TGFβ, cardiac fibroblasts, and the fibrotic responseCardiovascular Research, 2007
- Betaglycan induces TGF-β signaling in a ligand-independent manner, through activation of the p38 pathwayCellular Signalling, 2006
- Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B ReceptorsMolecular and Cellular Biology, 2006
- Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERKThe American Journal of Pathology, 2005
- Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcomeGene Therapy, 2003
- The modular architecture of a new family of growth regulators related to connective tissue growth factorPublished by Wiley ,2001
- The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and ApoptosisJournal of Bone and Mineral Research, 2001
- Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.Annals of the Rheumatic Diseases, 1994
- Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-βScience, 1987